These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10743023)

  • 1. [The concept of neuroprotection].
    Onténiente B
    Rev Neurol (Paris); 2000 Feb; 156(2):192-4. PubMed ID: 10743023
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroprotection: lessons from a spectrum of neurological disorders.
    Galpern WR; Singhal AB
    Int J Stroke; 2006 May; 1(2):97-9. PubMed ID: 18706052
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroprotection: extrapolating from neurologic diseases to the eye.
    Danesh-Meyer HV; Levin LA
    Am J Ophthalmol; 2009 Aug; 148(2):186-191.e2. PubMed ID: 19464671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection for Parkinson's disease: prospects and promises.
    Olanow CW; Schapira AH; Agid Y
    Ann Neurol; 2003; 53 Suppl 3():S1-2. PubMed ID: 12666093
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotrophins in neurodegenerative disease: theoretical issues and clinical trials.
    Olson L
    Neurochem Int; 1994 Jul; 25(1):1-3. PubMed ID: 7950962
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular delivery of trophic factors for the treatment of Huntington's disease: is neuroprotection possible?
    Kordower JH; Isacson O; Leventhal L; Emerich DF
    Prog Brain Res; 2000; 127():414-30. PubMed ID: 11142039
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanisms of neurotrophic factor protection against calcium- and free radical-mediated excitotoxic injury: implications for treating neurodegenerative disorders.
    Mattson MP; Cheng B; Smith-Swintosky VL
    Exp Neurol; 1993 Nov; 124(1):89-95. PubMed ID: 8282085
    [No Abstract]   [Full Text] [Related]  

  • 8. Lost in translation: again, another failed neuroprotection trial.
    Brew BJ
    Neurology; 2007 Sep; 69(13):1308-9. PubMed ID: 17893290
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic potential of neurotrophic factors for neurological disorders.
    Yuen EC; Mobley WC
    Ann Neurol; 1996 Sep; 40(3):346-54. PubMed ID: 8797524
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythropoietin as a novel neuroprotectant.
    Genc S; Koroglu TF; Genc K
    Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection and neuroplasticity - a holistic approach and future perspectives.
    Muresanu DF
    J Neurol Sci; 2007 Jun; 257(1-2):38-43. PubMed ID: 17331543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis.
    Loeb JA
    Neurology; 2007 May; 68(22 Suppl 3):S38-42; discussion S43-54. PubMed ID: 17548567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiopathologic mechanisms in acute progressive neuronal death: pharmaco-therapeutic consequences].
    Lepagnol J
    J Pharm Belg; 1997; 52(2):100-1. PubMed ID: 9296953
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunophilin ligands: from immunosuppressants to neuroprotective drugs].
    Tanaka K; Ogawa N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):71-4. PubMed ID: 15164613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection: a new strategy in the treatment of schizophrenia. Neurobiological basis of neurodegeneration and neuroprotection.
    Lieberman JA
    CNS Spectr; 2007 Oct; 12(10 Suppl 18):4-6. PubMed ID: 17934388
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of neurotrophic factors in the pathology and treatment of multiple sclerosis.
    Mirowska-Guzel D
    Immunopharmacol Immunotoxicol; 2009; 31(1):32-8. PubMed ID: 18792835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotrophic support and oxidative stress: converging effects in the normal and diseased nervous system.
    Gardiner J; Barton D; Overall R; Marc J
    Neuroscientist; 2009 Feb; 15(1):47-61. PubMed ID: 19218230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical marijuana: emerging applications for the management of neurologic disorders.
    Carter GT; Ugalde V
    Phys Med Rehabil Clin N Am; 2004 Nov; 15(4):943-54, ix. PubMed ID: 15458761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nerve growth factor in primate models of neurodegeneration: potential relevance in clinical neurology.
    Liberini P; Cuello AC
    Rev Neurosci; 1994; 5(2):89-104. PubMed ID: 7827710
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.